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ABSTRACT
Clinicians have been challenged in the past few years by an increasing variety of novel non-infectious
and infectious complications following the widespread use of meshes after open or laparoscopic repair
of hernias. The possibility of a mesh-related infection occurring weeks or even years after hernia repair,
should be considered in any patient with fever of unknown origin, or symptoms and ⁄ or signs of
inﬂammation of the abdominal wall following hernia repair. The reported incidence of mesh-related
infection following hernia repair has been 1%–8% in different series, and this incidence is inﬂuenced by
underlying co-morbidities, the type of mesh, the surgical technique and the strategy used to prevent
infections. An approach that combines medical and surgical management is necessary for cases of mesh
infection. The antimicrobial treatment regimen chosen initially should include coverage of Staphylococcus
spp. and, particularly, Staphylococcus aureus.
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INTRODUCTION
Within the last few years, the use of meshes has
become standard procedure in hernia repair
surgery throughout the world. Implantation of a
mesh during the surgical management of this
common problem has been found to reduce the
rate of recurrence of a hernia. For example, use of
a mesh for the repair of incisional hernias has
been found in different studies to decrease the
recurrence rates by an average of 30% [1–3], while
in a randomised clinical trial involving 289
patients in which non-mesh vs. mesh repair of
primary inguinal hernia was compared, it was
found that recurrence rates were 7% for the non-
mesh technique vs. 1% for mesh repair [4].
However, mesh-related complications have
become increasingly important. Such complica-
tions include seromas, adhesions, chronic severe
pain, migration and rejection of the mesh, and
mesh-related infections.
The present review focuses on mesh-related
infections. Data for the review were obtained
from searches of Medline, Current Contents and
references from relevant articles. In addition,
several articles were identiﬁed through searches
of the extensive ﬁles of the authors. The search
terms were ‘mesh’, ‘infection’, ‘open hernia sur-
gery’, ‘laparoscopic hernia repair’, ‘inguinal
hernia repair’, ‘infectious complications’, ‘bioma-
terials’, ‘antibiotic prophylaxis’ and ‘prevention’.
All English language papers were carefully
reviewed.
MESH-RELATED NON-INFECTIOUS
COMPLICATIONS
Important advances in research and development
by the biomedical materials industry have led to
the production of relatively inert and biocompat-
ible surgical meshes. However, it has been noted
in clinical practice that surgical meshes can
trigger various responses when implanted in the
human body, including inﬂammation (known as
foreign body reaction), ﬁbrosis, calciﬁcation,
thrombosis and infection.
Foreign body reaction refers to a process in
which proteins such as albumin and ﬁbrinogen
are absorbed initially by the surface of the poly-
mer. Subsequently, the physiochemical properties
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of each polymer result in the degradation of the
absorbed proteins. This process results in the
attraction and stimulation of macrophages, which
respond by releasing inﬂammatory substances
and growth factors. Other inﬂammatory cells
(T-lymphocytes, polymorphonuclear cells, eosin-
ophils, plasma cells and ﬁbroblasts) are then
attracted to the surface of the polymer, leading
to the formation of a granuloma. Such granulo-
mas are characterised by locally increased cell
turnover, which may continue for periods of
several years after the implantation of the mesh.
Foreign body reaction also depends on the surface
area of the mesh that is in contact with the host
tissue [5]. Clinical manifestations of foreign body
reaction are seroma, rejection, migration of mesh,
adhesions and pain.
Meshes made of non-absorbable polymers have
been used most frequently in clinical practice. The
main non-absorbable polymers are polyester,
polypropylene and expanded polytetraﬂuoroeth-
ylene. However, given the fact that absorbable
polymers are associated less frequently with
foreign body reactions and adhesion, newer
meshes are made of a combination of absorbable
and non-absorbable polymers [6,7]. The mechan-
ical and biological properties of meshes are
associated with the type of tissue structure
(woven or knitted) and the type of ﬁbre used
(mono- or multiﬁlament) [8]. The pore size of the
mesh also plays a role in the safety and tolerab-
ility of surgical meshes [9].
MESH-RELATED INFECTIOUS
COMPLICATIONS
Incidence
Mesh-related infections following surgery occur
relatively infrequently compared with other
device-related infections. However, they are of
considerable clinical importance, not only for the
patients and surgeons, but also for other medical
specialists. The question of whether the incidence
of infectious complications is higher after hernia
repair involving the use of a mesh, in comparison
with older techniques not involving use of a
mesh, remains controversial. The results of a
recent trial in which a comparison was made
between umbilical hernia repair with or without a
mesh in 200 adults showed that the rate of
post-operative complications, including infection,
was similar following both procedures [10]. A
similar result was obtained in a meta-analysis of
20 trials (5016 participants) of open mesh vs. non-
mesh repair of groin hernias [11]. In contrast, the
results of a randomised trial of 160 patients with
simple or complex hernias who underwent suture
repair, skin graft or mesh repair showed that the
rate of infectious complications was lower fol-
lowing suture repair than following the other two
techniques. In addition, mesh implantation led to
an increased rate of infections following repair of
both simple and complex hernias [12]. A further
study showed that the use of mesh during the
repair of a ventral hernia or a hernia defect
> 10 cm in size was associated signiﬁcantly with
an increased number of wound complications
[13].
Incidences of mesh-related infection after her-
nia repair of up to 8% have been reported
(Table 1) [14–18]. The rate of infection is inﬂu-
enced considerably by underlying co-morbidity,
and seems to be increased in patients with
diabetes, immunosuppression or obesity. Of great
interest is whether the type of prosthetic material
or the precise technique used for hernia repair can
inﬂuence the incidence of mesh infection. In most
recent published trials, the differences in compli-
cation rates following different surgical approa-
ches and the use of different meshes have been
compared. However, none of these studies
focused speciﬁcally on the mesh-related infection
rates. Leber et al. [19] conducted a retrospective
cohort analysis of 200 patients who underwent
open repair of abdominal incisional hernias with
prosthetic material, with the aim of determining
whether the incidence of long-term complications
was inﬂuenced by the surgical technique. The
authors concluded that the precise surgical
approach did not inﬂuence the incidence of
long-term complications signiﬁcantly, including
Table 1. Incidence of mesh infection after laparoscopic or
open hernia repair surgery
Reference
Study
population
(n) Technique of hernia repair
Incidence of
mesh
infection
Heniford et al. [14] 407 Laparoscopic ventral and
incisional hernia repair
0.98%
Heniford et al. [15] 822 Laparoscopic ventral
hernia repair
0.7%
Kirshtein et al. [16] 103 Laparoscopic incisional
hernia repair
2%
Petersen et al. [17] 121 Open incisional hernia repair 7%
Cobb et al. [18] 95 Open incisional hernia repair 8%
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mesh infection. Although several authors have
suggested that the laparoscopic approach to
hernia repair has fewer post-operative complica-
tions compared to open repair, there are no clear,
speciﬁc data regarding mesh-related infection
rates [20–22].
There is no consensus in the literature as to
whether the use of non-absorbable mesh for
incisional hernia repair is contraindicated in
potentially contaminated surgical settings.
Recently published data have indicated that the
rate of mesh-related infections is comparable for
‘clean’ surgical procedures and for cases where
potentially contaminated surgical procedures,
such as appendectomy, cholocystectomy or
enterectomy, are performed at the same time as
incisional hernia repair [23,24].
The inﬂuence of mesh type on the incidence of
infection was investigated in a recent study; the
results showed that the use of multiﬁlament
polyester mesh resulted in a higher incidence of
infection, small bowel obstruction and enterocu-
taneous ﬁstula formation than the use of other
types of mesh (knitted monoﬁlament polypropy-
lene, polytetraﬂuoroethylene or woven polypro-
pylene) [19]. In addition, studies in experimental
animals have shown that microporous mesh is
associated with higher rates of infection and ⁄ or
development of seromas, whereas macroporous
mesh is associated with a higher incidence of
adhesive and erosive events. Microporous mesh
has a pore diameter of 10 lm, with the result that
bacteria can penetrate the mesh, but polymor-
phonuclear leukocytes (with a diameter of 75 lm)
cannot. This means that the bacteria in the mesh
are protected from immunological defence mech-
anisms [25–27].
Clinical symptoms and signs
The reported interval between hernia repair and
the manifestation of a mesh infection ranges from
2 weeks to 39 months [28]. Patients usually pre-
sent with symptoms and signs of local acute
inﬂammation (a combination of pain, erythema,
tenderness, swelling and increased temperature
in the abdominal wall in the area of the mesh). In
addition, patients may have systemic manifesta-
tions such as fever, malaise, chills or rigors. A
mesh-related infection can sometimes manifest
with a discharging ﬁstula, or with an intra-
abdominal abscess. Rare cases of patients who
presented with osteomyelitis following inguinal
hernia surgery with implantation of a polypropy-
lene mesh have been reported [29].
Microbiology
The usual causative organisms associated with
cases of mesh infection are Staphylococcus spp.,
especially Staphylococcus aureus, Streptococcus spp.
(including group B streptococci), Gram-negative
bacteria (mainly Enterobacteriaceae), and anaer-
obic bacteria (including Peptostreptococcus spp.)
[28]. In a study of mesh-related infections follow-
ing incisional herniorrhaphy, 63% of the micro-
organisms isolated were methicillin-resistant
S. aureus (MRSA) [18]. Rarely, mesh infections
are caused by Candida spp. or Mycobacterium spp.
[30,31].
Mesh infections can manifest with chronic,
persistent or recurrent symptoms and signs. The
infecting agents in some of these reported cases
were small-colony variants, usually of S. aureus.
The main characteristic of these infections is that
they respond poorly to antimicrobial treatment
regimens [32].
Prevention
The most important point regarding the preven-
tion of mesh-related infections is that foreign
body reactions depend on the amount of the
prosthesis (mesh) used. For this reason, surgeons
should try to minimise the area of mesh that is
introduced during the hernia operation, since the
inserted foreign material is an ideal medium for
bacterial colonisation [33].
In addition, four main approaches to the
prevention of mesh infection have been used.
First, the wound can be rinsed with an antibiotic-
containing solution, starting immediately after the
dissection of the hernia sac, and then intermit-
tently until the skin is sutured. It has been shown
in an animal model that this approach inhibits the
adhesion of bacteria to the surface of the mesh, as
well as their growth [34]. Moreover, in a rand-
omised trial of 162 patients who underwent
inguinal hernia repair, there were no wound
infections following the application of a single
dose of cefamandole directly to the wound [35].
However, the effectiveness of lavage with
solutions containing antimicrobial agents is con-
troversial, since antibiotics require a deﬁned
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duration of contact with pathogens, while lavage
is usually a more rapid process.
A second approach involves the use of material
placed in front of the mesh to slowly deliver an
antimicrobial agent locally. In a randomised trial,
the use of gentamicin-laced collagen tampons was
tested in 301 patients undergoing prosthetic groin
hernia repair. The collagen tampons were placed
in front of the mesh before the aponeurosis of the
external oblique muscle was sutured. This new
technique resulted in fewer post-operative infec-
tions in comparison with 294 patients undergoing
surgical repair for the same hernia without the
use of gentamicin-containing collagen tampons
[36].
Third, a mesh containing embedded antimicro-
bial agents can be used. Such a mesh is thought to
help prevent bacterial adhesion and colonisation
when implanted in wounds, with a subsequent
reduced likelihood of post-operative infections.
Finally, traditional intravenous perioperative
administration of antimicrobial agents can be
used. Although hernia repair operations are
classiﬁed as clean surgery, the administration of
intravenous antibiotics perioperatively has been
shown to be beneﬁcial if a prosthetic material
(mesh) is involved [37,38].
All of the above-mentioned strategies seem to
be beneﬁcial in reducing the incidence of mesh-
related infection after hernia repair. However, no
deﬁnitive recommendation can be made in favour
of any particular approach in the absence of
comparative outcome data. The current standard
preventive strategy for other types of surgery, i.e.,
the perioperative administration of appropriate
intravenous antibiotics, may be used until new
data regarding alternative preventive strategies
become available. At the present time, additional
strategies to prevent mesh-related infections, such
as the use of gentamicin-laced collagen tampons
with a mesh, are best reserved for patients at high
risk of infection, such as diabetic and obese
patients.
Diagnosis and treatment
A clinician should strongly consider the possibil-
ity of a mesh-related infection in any patient who
presents with fever of unknown aetiology, symp-
toms and ⁄ or signs of inﬂammation of the abdom-
inal wall in the area of the mesh, or other less
common clinical manifestations of mesh infection,
such as an enterocutaneous ﬁstula or abdominal
abscess in the area of the mesh.
Imaging techniques, including ultrasound
and ⁄ or computerised tomography, can be useful
for the diagnosis of mesh infection. Such tech-
niques usually reveal an area of inﬂammation in
the subcutaneous fat around the mesh, which has
different echogenic or density characteristics,
respectively, from that in other conditions, such
as seroma. Additionally, the results of these
imaging tests can indicate the presence of a ﬁstula
or an abscess.
It is important that no attempt should be made
to perform a diagnostic paracentesis of mesh-
related seromas when there are no symptoms
and ⁄ or signs of inﬂammation of the abdominal
wall. This is because of the real possibility of
introduction of bacteria into the area of seroma
during paracentesis, leading to the transformation
of an aseptic reaction into an infectious process.
When a mesh-related infection occurs, a com-
bined medical and surgical approach involving
intravenous antimicrobial agents and complete
surgical removal of the mesh is the preferred
management strategy. For a variety of reasons,
monotherapy with intravenous antibiotics gener-
ally has a poor outcome. The most important of
these reasons relates to the ﬁbroblastic response
of the organism to the polymer of the implanted
mesh, which results in the development of a thick
ﬁbrous capsule surrounding the mesh. Conse-
quently, when an infection is established, this
capsule restricts the penetration of antimicrobial
agents into the infected mesh. In addition, it is
well known that Staphylococcus spp., which are the
most common causative organisms in mesh infec-
tions, produce a bioﬁlm on the prosthesis, with
the result that the microorganisms are protected
simultaneously from antibiotics and the immune
responses of the host organism [39].
Incomplete removal of the mesh should be
suspected in any case with persistent or recurrent
symptoms and ⁄ or signs of mesh infection. How-
ever, the results of a recent study suggested that
the management of infected mesh might differ
according to the type of mesh used. Speciﬁcally, it
was suggested that infection of polyester or
polypropylene mesh might be managed with
drainage and antimicrobial agents only, whereas
the infected mesh should be surgically removed
in cases of infection involving expanded poly-
tetraﬂuoroethylene mesh [17].
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CONCLUSIONS
Clinicians should promptly consider the possibil-
ity of mesh infection in any patient who has
undergone hernia repair surgery involving a
mesh, and who has fever of unknown aetiology
or symptoms and ⁄ or signs of infection of the
abdominal wall. There is no adequate evidence in
the literature concerning the speciﬁc risk factors
for such infections. Whether the surgical tech-
nique used for the repair of a hernia or the precise
type of implanted mesh inﬂuences the rate of
development of a mesh-related infection remains
to be clariﬁed.
As yet, there are no published reports of com-
parative trials of different antimicrobial regimens
for the management of mesh-related infections.
Consequently, no deﬁnitive recommendations can
be made concerning the preferred medical man-
agement strategy. However, given the known facts
regarding the microbial aetiology of mesh-related
infections, and thepathogenesis and characteristics
of infections involving other types of prosthetic
material, antimicrobial agents used for the treat-
ment of mesh-related infection should at least
include coverage for Staphylococcus spp.
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